Stempoint Capital’s Cymabay Therapeutics CBAY Stock Holding History

Stempoint Capital’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-182,258	Closed	-$4.3M	–	100
2023 Q4	$4.3M	Buy	+182,258	New	+$3.25M	1.15%	35

Other funds holding CBAY

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Stempoint Capital's CBAY Position: Q1 2024 in Review

Stempoint Capital sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 182,258 shares — an estimated $4.3M sold.

Stempoint Capital first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $4.3M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Stempoint Capital reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Stempoint Capital sold 182,258 Cymabay Therapeutics shares in Q1 2024, an estimated $4.3M.
Stempoint Capital first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
Stempoint Capital's Cymabay Therapeutics position peaked at $4.3M in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Stempoint Capital's 13F filing for Q1 2024, filed 14 May 2024.